|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/14/23 Salona Global Medical Device Corp 10-Q 6/30/23 85:10M Newsfile Corp./FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report -- form10q HTML 1.87M
2: EX-2.1 Plan of Acquisition, Reorganization, Arrangement, HTML 126K
Liquidation or Succession -- exhibit2-1
3: EX-31.1 Certification -- §302 - SOA'02 -- exhibit31-1 HTML 25K
4: EX-31.2 Certification -- §302 - SOA'02 -- exhibit31-2 HTML 25K
5: EX-32.1 Certification -- §906 - SOA'02 -- exhibit32-1 HTML 23K
6: EX-32.2 Certification -- §906 - SOA'02 -- exhibit32-2 HTML 23K
12: R1 Document and Entity Information HTML 72K
13: R2 Unaudited Interim Condensed Consolidated Balance HTML 134K
Sheets
14: R3 Unaudited Interim Condensed Consolidated Balance HTML 37K
Sheets (Parentheticals)
15: R4 Unaudited Interim Condensed Consolidated HTML 135K
Statements of Operations and Comprehensive Loss
16: R5 Unaudited Interim Condensed Consolidated HTML 135K
Statements of Stockholders' Equity
17: R6 Unaudited Interim Condensed Consolidated HTML 128K
Statements of Cash Flows
18: R7 Description of the business HTML 31K
19: R8 Basis of presentation and going concern HTML 30K
20: R9 Significant accounting policies HTML 80K
21: R10 Acquisitions HTML 137K
22: R11 Accounts receivable HTML 30K
23: R12 Disaggregation of revenues HTML 25K
24: R13 Inventories HTML 31K
25: R14 Property and equipment HTML 89K
26: R15 Intangible assets HTML 69K
27: R16 Accounts payable and accrued liabilities HTML 31K
28: R17 Line of credit and debt HTML 59K
29: R18 Leases HTML 56K
30: R19 Stockholders' equity HTML 105K
31: R20 Related party transactions HTML 33K
32: R21 Transaction costs HTML 34K
33: R22 Cash and cash equivalents HTML 25K
34: R23 Income taxes HTML 29K
35: R24 Other income HTML 27K
36: R25 Contingencies HTML 27K
37: R26 Subsequent events HTML 27K
38: R27 Significant accounting policies (Policies) HTML 134K
39: R28 Significant accounting policies (Tables) HTML 32K
40: R29 Acquisitions (Tables) HTML 129K
41: R30 Accounts receivable (Tables) HTML 30K
42: R31 Inventories (Tables) HTML 31K
43: R32 Property and equipment (Tables) HTML 88K
44: R33 Intangible assets (Tables) HTML 69K
45: R34 Accounts payable and accrued liabilities (Tables) HTML 31K
46: R35 Line of credit and debt (Tables) HTML 45K
47: R36 Leases (Tables) HTML 52K
48: R37 Stockholders' equity (Tables) HTML 98K
49: R38 Transaction costs (Tables) HTML 33K
50: R39 Description of the business (Narrative) (Details) HTML 46K
51: R40 Significant accounting policies (Narrative) HTML 32K
(Details)
52: R41 Significant accounting policies - Schedule of HTML 47K
estimated useful lives of property and equipment
(Details)
53: R42 Significant accounting policies - Schedule of HTML 33K
estimated useful lives of Intangible asset
(Details)
54: R43 Acquisitions (Narrative) (Details) HTML 195K
55: R44 Acquisitions - Schedule of allocation of purchase HTML 132K
price (Details)
56: R45 Acquisitions - Schedule of goodwill and other HTML 66K
intangible assets (Details)
57: R46 Acquisitions - Schedule of value of total HTML 84K
consideration (Details)
58: R47 Accounts receivable - Schedule of accounts HTML 34K
receivable (Details)
59: R48 Disaggregation of revenues (Narrative) (Details) HTML 27K
60: R49 Inventories - Schedule of inventories (Details) HTML 33K
61: R50 Property and equipment - Schedule of property and HTML 129K
equipment (Details)
62: R51 Intangible assets - Schedule of intangible assets HTML 87K
(Details)
63: R52 Accounts payable and accrued liabilities HTML 26K
(Narrative) (Details)
64: R53 Accounts payable and accrued liabilities - HTML 32K
Schedule of accounts payable and accrued
liabilities (Details)
65: R54 Line of credit and debt (Narrative) (Details) HTML 177K
66: R55 Line of credit and debt - Schedule of debt HTML 69K
(Details)
67: R56 Leases (Narrative) (Details) HTML 102K
68: R57 Leases - Schedule of right-of-use assets and lease HTML 50K
liabilities (Details)
69: R58 Leases - Schedule of future minimum lease payments HTML 49K
payable (Details)
70: R59 Stockholders' equity (Narrative) (Details) HTML 255K
71: R60 Stockholders' equity - Schedule of outstanding HTML 106K
stock options (Details)
72: R61 Stockholders' equity - Schedule of changes to HTML 44K
stock options (Details)
73: R62 Stockholders' equity - Schedule of outstanding HTML 40K
warrants (Details)
74: R63 Stockholders' equity - Schedule of summary of HTML 41K
warrants (Details)
75: R64 Related party transactions (Narrative) (Details) HTML 48K
76: R65 Transaction costs - Schedule of transaction costs HTML 31K
including legal, audit and US regulatory (Details)
77: R66 Cash and cash equivalents (Narrative) (Details) HTML 25K
78: R67 Income taxes (Narrative) (Details) HTML 27K
79: R68 Other income (Narrative) (Details) HTML 30K
80: R69 Subsequent events (Narrative) (Details) HTML 44K
83: XML IDEA XML File -- Filing Summary XML 151K
81: XML XBRL Instance -- form10q_htm XML 2.46M
82: EXCEL IDEA Workbook of Financial Report Info XLSX 224K
8: EX-101.CAL XBRL Calculations -- sgmd-20230630_cal XML 154K
9: EX-101.DEF XBRL Definitions -- sgmd-20230630_def XML 839K
10: EX-101.LAB XBRL Labels -- sgmd-20230630_lab XML 3.72M
11: EX-101.PRE XBRL Presentations -- sgmd-20230630_pre XML 1.21M
7: EX-101.SCH XBRL Schema -- sgmd-20230630 XSD 383K
84: JSON XBRL Instance as JSON Data -- MetaLinks 554± 821K
85: ZIP XBRL Zipped Folder -- 0001062993-23-016445-xbrl Zip 455K
| Salona Global Medical Device Corp.: Exhibit 32.2 - Filed by newsfilecorp.com |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Dennis Nelson, the Chief Financial Officer of Salona Global Medical Device Corporation (the "Registrant"), hereby certifies that, to the best of his knowledge:
1. The Registrant's Quarterly Report on Form 10-Q for the period ended June 30, 2023, to which this Certification is attached as Exhibit 32.2 (the "Periodic Report"), fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and
2. The information contained in the Periodic Report fairly presents, in all material respects, the financial condition of the Registrant at the end of the period covered by the Periodic Report and results of operations of the Registrant for the periods covered by the Periodic Report.
| Date: August 14, 2023 | /s/ Dennis Nelson |
| Dennis Nelson | |
| Chief Financial Officer | |
| (Principal Financial Officer) |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/14/23 | None on these Dates | ||
| For Period end: | 6/30/23 | |||
| List all Filings | ||||